台耀化學股份有限公司
台耀化學股份有限公司（Formosa Laboratories, Inc.）及其子公司製造銷售原料藥（API）及紫外線吸收劑。提供抗癌、維生素 D 衍生物、抗炎止痛、免疫調節及心血管藥物原料。亦提供 CDMO 委託研製服務，包含抗體藥物複合體（ADC）之開發與製造。公司成立於 1985 年，總部位於台灣桃園。
該股 RSI(6) 為 77.9，處於偏高區間，短線追高風險提升。股價站上5日、20日、60日、120日均線。KD 指標偏高（K=84.1），追高宜謹慎；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +75 | 0 | 0 | +75 |
| 08-07 | +652 | 0 | +2 | +654 |
| 08-06 | +74 | 0 | 0 | +74 |
| 08-05 | +126 | 0 | +40 | +166 |
| 08-04 | +189 | 0 | +94 | +283 |
| 08-03 | +176 | 0 | +81 | +257 |
| 07-31 | +136 | 0 | 0 | +136 |
| 07-30 | -41 | 0 | +1 | -40 |
| 07-29 | -377 | 0 | +3 | -374 |
| 07-28 | -234 | 0 | -5 | -239 |
| 07-27 | -13 | 0 | +22 | +9 |
| 07-24 | -350 | 0 | +28 | -323 |
| 07-23 | -225 | 0 | -2 | -227 |
| 07-22 | -39 | 0 | -3 | -42 |
| 07-21 | -26 | 0 | +2 | -24 |
| 07-20 | -161 | 0 | 0 | -161 |
| 07-17 | -141 | 0 | -5 | -147 |
| 07-16 | -37 | 0 | +1 | -36 |
| 07-15 | +129 | 0 | +2 | +131 |
| 07-14 | -204 | 0 | -4 | -208 |
| 07-13 | -28 | 0 | +1 | -28 |
| 07-09 | -8 | 0 | -2 | -9 |
| 07-08 | -14 | 0 | +5 | -9 |
| 07-07 | +282 | 0 | +7 | +289 |
| 07-06 | +511 | 0 | +2 | +514 |
| 07-03 | +477 | 0 | +5 | +481 |
| 07-02 | +2 | 0 | -9 | -7 |
| 07-01 | +221 | 0 | +6 | +227 |
| 06-30 | +393 | 0 | +3 | +395 |
| 06-29 | +437 | 0 | +13 | +450 |
| 06-26 | -310 | 0 | -5 | -315 |
| 06-25 | -275 | 0 | 0 | -275 |
| 06-24 | +226 | 0 | +3 | +229 |
| 06-22 | +57 | 0 | +1 | +58 |
| 06-18 | +70 | 0 | -7 | +63 |
| 06-17 | +86 | +49 | +1 | +136 |
| 06-16 | -16 | 0 | 0 | -16 |
| 06-15 | +116 | 0 | +1 | +117 |
| 06-12 | +162 | 0 | 0 | +162 |
| 06-10 | +78 | 0 | -3 | +75 |
| 06-09 | -15 | 0 | -2 | -17 |
| 06-08 | +269 | 0 | -2 | +267 |
| 06-04 | +78 | 0 | +2 | +80 |
| 06-03 | +88 | 0 | 0 | +89 |
| 06-02 | -226 | -55 | +1 | -280 |
| 06-01 | +212 | 0 | +1 | +214 |
| 05-29 | +711 | 0 | +5 | +716 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 4.22 億 | +17.6% | +0.3% |
| 2026/05 | 3.59 億 | +8.5% | -4.9% |
| 2026/04 | 3.31 億 | -27.5% | -25.7% |
| 2026/03 | 4.56 億 | +95.9% | -6.0% |
| 2026/02 | 2.33 億 | -38.0% | -20.5% |
| 2026/01 | 3.75 億 | -28.7% | +2.5% |
| 2025/12 | 5.27 億 | +40.0% | -2.4% |
| 2025/11 | 3.76 億 | -6.4% | -12.8% |
| 2025/10 | 4.02 億 | -3.9% | +5.4% |
| 2025/09 | 4.18 億 | +14.0% | +14.4% |
| 2025/08 | 3.66 億 | -2.7% | +8.4% |
| 2025/07 | 3.76 億 | - | +14.9% |